top of page
All Posts
DIFFERENT CLOCKS: WHAT ORGAN-SPECIFIC AGING RESEARCH MEANS AT THE POINT OF CARE
A Practiced. clinical reference article for licensed clinicians, November 2026 Not medical advice. Confirm dose and indication before prescribing. THE FINDING Two patients present on the same day, both 60. One is lifting, working, sharp. The other is three years into fatigue, sarcopenia and a slow slide in recovery. We have all written that second chart, and most of us have reached for the same unsatisfying phrase: deconditioning, age-related. Three lines of research over the
monikaerod
Nov 75 min read


What Order Do You Treat Mold In? A Clinician's Treatment Sequence
Most mold cases that stall don't stall because the clinician reached for the wrong binder or the wrong antifungal. They stall because the right tools were used in the wrong order. Mold and mycotoxin illness is one of the few areas of medicine where sequence is the treatment — and where getting it out of order reliably makes patients worse. This guide lays out the order that works, the rule that governs all of it, and the sequencing mistakes that send sensitive patients into w
monikaerod
Aug 54 min read


Are Peptides Legal in 2026? A Clinician's Guide to the Regulatory Landscape
Non–FDA-approved isn't the same as illegal. A clear, current guide to peptide legality, the 2026 FDA changes, sourcing, and how clinicians stay compliant.
monikaerod
Aug 34 min read


BPC-157: What Practitioners Actually Need to Know
An evidence-based BPC-157 guide for clinicians: mechanism, the real state of the human evidence, safety, and the shifting 2026 FDA compounding status.
monikaerod
Jul 183 min read


TB-500: What Practitioners Actually Need to Know
An evidence-based look at TB-500 / thymosin β4 for clinicians: the Tβ4-vs-TB-500 distinction, mechanism, the real state of the human evidence, safety, and the 2026 FDA compounding status.
monikaerod
Jul 174 min read
bottom of page